MMRGlobal CEO Robert H. Lorsch Blogs About Personal Health

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MMRGlobal CEO Robert H. Lorsch Blogs About Personal Health Records, Wizardry and Humanitarian Efforts to Free Dr. Afridi

LOS ANGELES, CA--(Marketwired - May 13, 2013) - Robert H. "Bob" Lorsch, CEO of MMRGlobal, Inc. ( OTCQB : MMRF ), blogs about the Company and humanitarian and philanthropic efforts to Free Dr. Shakil Afridi. This blog and others can also be viewed at http://blog.mmrglobal.com .

Go Behind The Curtain & Ask The Wizard...

He will tell you, "it is real, it always will be, and it exists in and beyond every corner of every alternate universe"... so says Richard Bach.

I have spent the last four years blogging about the magic inside that keeps me motivated. Many have criticized me for being a frustrated version of Richard Bach; however, nothing could be further from the truth. I write my blogs the way I do because it works for me. Some readers might say that I should focus my writing more about the business of MMR, but what fun would that be, after all, if you can't make money and have fun is it really worth it. The fact is that when I put myself out there personally I still get lots of the comments about MMR, but I also get comments about how I make a difference in other people's lives, and that makes me feel good.

One example is Dr. Shakil Afridi ( www.freeafridi.com ), who is sitting in a dungeon in Pakistan after sacrificing his family so that he could help America pinpoint the location of Osama bin Laden. Kira and I have received a landslide of worldwide press from our efforts creating a campaign to free Dr. Afridi in order to call attention to this important humanitarian crisis. As a result of our efforts and the efforts of the employees at MMR, we received worldwide coverage last week, from London's " Daily Mail " and Page 6 of the " New York Post " to Breitbart . Being who I am allows me to run MMRGlobal, a publicly traded company under MMRF, while keeping MMR in the spotlight and giving back by calling attention to humanitarian and philanthropic issues in the world like the plight of Dr. Shakil Afridi. 

Now I am going to talk about MMR and how my Bach-like belief system is turning the dream of an emerging growth opportunity into the reality of a business which could hold more than one billion dollars worth of intellectual property rights for its shareholders. MMR is a company that was founded to facilitate better care by reducing medical costs and helping save lives. MMR is a journey I embarked on as a result of my own life experiences and my fight to survive a deadly form of cancer 13 years ago which I did.

As I sit down to let my fingers do the walking, I realized that it was time to let you see how it's possible that a person can turn a dream into a reality by simply wanting it to be so. This is the second time in my life I have entered an industry that was dominated by multi-billion dollar companies in communications or healthcare. 

I entered both opportunities as the underdog, first competing in telecommunications, then health IT. The first time, based on will and determination, I knew I won big when I went public standing on the floor of the Nasdaq. This time I know we are winning based on the fact that we continue to hit consistent singles in the healthcare business and doubles and triples with our health IT and biotech patent portfolios.

So let's travel to behind the curtain in Oz so you can actually see what the future could have in store for all of us. I believe that when you resist change you are stuck with what you have. So in my world, I never resist change and I am always exploring places to visit on a never-ending canvas. Despite an extraordinary, unexplainable trading range in our stock, the direction is clearly up. MMR's world promises to continue coming alive with a high quality group of strategic partners and customers. We no longer have to beat people over the head to get them to use a Personal Health Record . Now we can focus on delivering products and services. So as a result of consumer and professional awareness of PHRs and requirements to deploy them, we should begin to see revenues from operations and licensing far greater that any projected in the past.

E-Health is finally a reality of our time just like the evolution of other industries like credit monitoring services (which took forever to evolve), online banking services (which took forever to evolve), online travel services (which took forever to evolve), and online retail (which took forever to evolve). E-Health is now fast becoming a way of life. And after eight long years, MMR is well positioned to benefit from that industry growth by exploiting the marketplace, much like Amazon did in retail, PayPal in payment processing, and eBay in auctions and commerce, to name only a few.

As CEO of the Company, I could not be more excited about how this year is progressing, and all the things that lie ahead. For those who have followed this company since inception, when I have said, "the best is yet to come," it means just that. For example, last week we spent a half-day in meetings with Sodexo regarding PHR offerings and an MMRPro distribution program internationally. We also met with representatives of the new employee owners of Kodak, who paid us a visit to help celebrate their purchase of Kodak's Document Imaging business and other assets. This means supply lines from Kodak in the future for MMRPro has never looked better.

Our relationships with all our strategic vendors and partners are excellent; from Nihilent to ng Connect to Unis-Tonghe, and Interbit Data, Fujitsu, Kodak, and many others. We continue to make significant progress in Australia and, in fact, one of our larger Australian strategic partners was in Los Angeles over the weekend helping us prepare for meetings with government officials in Australia next month. We are also getting close to significant announcements in Singapore.

During the week, we continued ongoing dialogue with WebMD and we met with Quest Diagnostics at their offices near San Diego. While we work through strategic business opportunities with both WebMD and Quest, we are also in meaningful conversations with half of the top 10 EMR vendors, including McKesson and Cerner, with whom the Company has already enjoyed a five-year licensing relationship. We are also getting closer to a major announcement with a wireless carrier where healthcare continues to be a major priority and agenda item. In all cases, and with all these opportunities, the Company continues to actively pursue other licensing and strategic business opportunities both here and abroad, as evidenced by last week's announcement about the Middle East. 

And to the extent relationships involve more than strategic conversations, we are keeping the investment banking team at B. Riley very busy. While all this goes on, the Company continues filing additional patent infringement and trademark actions.

Speaking of patents, the Company's United States health IT portfolio has recently been re-valued to add Japan which increased it to as much as $1.3 billion. As yet, the Company does not have a valuation on Australia, Singapore, South Korea, Hong Kong, New Zealand, Mexico, Canada, Israel, and European nations which when added could increase the number significantly. Australia and Singapore are currently the subject of active investigation into infringement matters at this time.  http://phx.corporate-ir.net/phoenix.zhtml?c=1...&highlight .

The MMR Patent Portfolio was created about the same time that the Office of the National Coordinator for Health Information Technology was formed. The MMR Patent Portfolio was granted over nearly an eight-year period of time as part of a multi-million dollar effort to create shareholder value through the ownership of patents and other intellectual property in 12 countries around the globe. Because there are thousands of patented products in every healthcare professional's office and hospital, from the design of a handle on a scalpel to components of the most sophisticated imaging equipment, the healthcare industry has shown it respects the patent system, and, based on our experience so far, we feel good about our ability to license and monetize these patents on behalf of our shareholders. In fact, we are not aware of a situation where an industry has paid so much attention to the value of a patent portfolio since Samsung and Apple went to court, which further makes us feel good about the future. 

The fact that the MMR patents are the subject of worldwide media attention, and in the United States alone, the Company believes that more than 3000 hospitals and healthcare providers do, or will, infringe on the Company's IP by the end of 2014, should make for a very good next few years.

In closing, my favorite Bachism is, "You are never given a wish without the power to make it true. You may have to work for it, however." So Kira, I am sorry I will be late for dinner tonight. 

Robert H. "Bob" Lorsch, CEO, MMRGlobal 4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010, Tel. 310-476-7002 www.mmrglobal.com www.mymedicalrecords.com Follow us on Twitter at MMRGlobal

MEDIA CONTACT: Michael Selsman Public Communications Co. (310) 922-7033 ms@publiccommunications.biz

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 64

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
University of Phoenix Leads Credentialing Dialogue at Summit

Updated Category News Views 42

Credentials in the Spotlight at PESC Summit When you're talking credentials and data standards at the PESC Summit, you've got a gathering of big brains aiming to steer the wild ride of higher education into the future. This October, University of Phoenix leaders stepped up to the plate in Scottsdale, Arizona, delivering a frank talk about the role of credentials in...

Continue Reading
Co-op Giants Earn $309B: Key Players Spotlighted

Updated Category News Views 188

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...

Continue Reading
ADT Shareholders Face Legal Scrutiny in M&A Deal

Updated Category News Views 19

ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...

Continue Reading
Class Action Looms Over Tenax Therapeutics Investors

Updated Category News Views 51

Shareholders in the Crosshairs Every once in a while, the market serves up a cold dish of reality, and folks owning Tenax Therapeutics (NASDAQ:TENX) are facing just that. A class action is casting a long shadow, targeting those who bought in between November 13, 2023, and August 7, 2026. It's the kind of headache that no investor wakes up hoping for. The Allegations: When...

Continue Reading
PRTH Shareholder Concerns Amid Merger Investigation

Updated Category News Views 79

Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....

Continue Reading
Investigations Target PAG, BRBS, PSNL for Fair Shareholder Deals

Updated Category News Views 64

Unpacking the Shareholder's Dilemma in Major Transactions Alright, folks, let's dig into this mess with our favorite Wall Street magnifying glass. We've got Penske Automotive Group (NYSE: PAG), Blue Ridge Bankshares (NYSE: BRBS), and Personalis, Inc. (NASDAQ: PSNL) under the spotlight, each locking themselves into deals that might not exactly scream 'fair play' for the...

Continue Reading
The Sift: Slickdeals’ Game-Changing Black Friday Tool

Updated Category News Views 272

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Continue Reading
Holiday Shoppers Eye Payment Options Amid Tight Budgets

Updated Category News Views 59

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

Continue Reading
Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

Updated Category News Views 80

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments in Titanium Powder Production by PyroGenesis

Updated Category News Views 156

Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...

Continue Reading
Exploring The Impressive Returns of The Hartford Insurance

Updated Category News Views 254

Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...

Continue Reading
Exciting New Consumer Product Launches and Trends This Week

Updated Category News Views 520

Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...

Continue Reading
Occidental Petroleum's Significant Debt Reduction Achievements

Updated Category News Views 274

Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...

Continue Reading
Aptose Unveils Promising New Therapy for AML Patients

Updated Category News Views 218

Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...

Continue Reading